Glycogen storage disease type III: a mixed-methods study to assess the burden of disease.

Ayla EvinsJill MayhewTricia CimmsJulie WhyteKathy VongElizabeth HribalChristopher J EvansAndrew Grimm

Published in: Therapeutic advances in endocrinology and metabolism (2024)

Individuals with GSD III experience a broad spectrum of symptoms and disease impacts. There is an unmet need for therapies that improve metabolic control, reduce the burden of dietary management, reduce fatigue and liver problems, and improve muscle strength and function.

Keyphrases

type iii
mental health
sleep quality
risk factors
depressive symptoms